Cassiopea announces 2019 Results in line with expectations
Cassiopea S.p.A., a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today results for the year ended 31 December 2019.